WallStreetZenWallStreetZen

NASDAQ: BCTX
Briacell Therapeutics Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BCTX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$12.6M
Current Profit Margin
0%

BCTX Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when BCTX announces earnings.

BCTX Return on Assets

Current Company
-57.7%
Current Industry
2.9%
BCTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BCTX Return on Capital Employed

Current Company
-207.41%
Current Industry
19.5%
BCTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BCTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BCTX$0.00-$17.21M-$12.65MN/AN/A
NXTC$0.00-$58.47M-$62.72M-100.00%N/A
BCLI$0.00-$16.48M-$17.19MN/AN/A
ICU$0.00-$25.15M-$26.23MN/AN/A
TARA$0.00-$40.08M-$40.42MN/AN/A
View Top Biotech Stocks

BCTX earnings dates

Next earnings date
Jun 10, 2024

Briacell Therapeutics Earnings & Revenue FAQ

What were BCTX's earnings last quarter?

On Invalid Date, Briacell Therapeutics (NASDAQ: BCTX) reported Q4 2023 earnings per share (EPS) of -$0.71, up 7.79% year over year. Total Briacell Therapeutics earnings for the quarter were -$11.33 million. In the same quarter last year, Briacell Therapeutics's earnings per share (EPS) was -$0.77.

If you're new to stock investing, here's how to buy Briacell Therapeutics stock.

What was BCTX's earnings growth in the past year?

As of Q2 2024, Briacell Therapeutics's earnings has grown year over year. Briacell Therapeutics's earnings in the past year totalled -$12.65 million.

What is BCTX's earnings date?

Briacell Therapeutics's earnings date is Invalid Date. Add BCTX to your watchlist to be reminded of BCTX's next earnings announcement.

What was BCTX's revenue last quarter?

On Invalid Date, Briacell Therapeutics (NASDAQ: BCTX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Briacell Therapeutics's revenue was $0.00.

What was BCTX's revenue growth in the past year?

As of Q2 2024, Briacell Therapeutics's revenue has grown null year over year. Briacell Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.